Truveta
PrivateLast Round
Series C
Jan 13, 2025
Est. Valuation
$1B
Total Funding Raised
$515M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Truveta is a health technology company that provides a platform for aggregating and de-identifying electronic health record data to support medical research and clinical decision-making.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Clinical Trials, Medical AI, Data Governance, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truveta Comparables
Compare Truveta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| nference | 86% | |
| Verana Health | 85% | |
| Komodo Health | 84% |
Truveta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 13, 2025 | ||||
| Series B | Nov 9, 2021 | ||||
| Series A Extension | Sep 29, 2021 | ||||
| Series A | Jul 13, 2021 |
Key People
Founding team and executive leadership
Truveta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ochsner Ventures | Series B |
| Catholic Health Initiatives | Series A, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Company maintains ISO 27001 certification.
- Apr 23, 2026
Maintains an ISO 27701 certification extension.
Recent news
Latest coverage and updates
- launchesAug 6, 2026
Truveta launched AI-enabled data platform on Aug 6th '26.
Truveta Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Truveta's valuation, stock price, and market status.
Is Truveta a public or private company?
Truveta is a private company.
What is the current stock price of Truveta?
Truveta is a private company, so its shares have no public market price. Caplight tracks Truveta's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Truveta worth (valuation)?
Truveta's valuation is estimated at $1.0B based on funding round data.
Can I buy Truveta stock?
Truveta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Truveta's last funding round?
Truveta's most recent funding round was Series C on January 13, 2025.
Who are the main investors in Truveta?
Key investors in Truveta include Ochsner Ventures, Catholic Health Initiatives.
Will Truveta IPO soon?
No public IPO plans have been announced for Truveta.
How can I track Truveta secondary market activity?
Caplight tracks bids, offers, and trades in Truveta's shares on secondary markets.